Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Finkbeiner

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Neurology|October 15, 2014
Targeting the low-hanging fruit of neurodegenerationAmanda R Mason, Adam Ziemann, Steven Finkbeiner
The Journal of Biological Chemistry|June 2, 2024
Three dimensional and four dimensional live imaging to study mechanisms of progressive neurodegenerationJeremy W Linsley, Terry Reisine, Steven Finkbeiner
Methods in Molecular Biology (Clifton, N.J.)|May 31, 2013
Longitudinal imaging and analysis of neurons expressing polyglutamine-expanded proteinsAndrey S Tsvetkov, D Michael Ando, Steven Finkbeiner
Stem Cell Research|November 4, 2021
Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson's patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)Gabriela Novak, Steven Finkbeiner, Gaia Skibinski, et al.
Stem Cell Research|November 26, 2021
Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson's disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)Gabriela Novak, Steven Finkbeiner, Gaia Skibinski, et al.
The Journal of Biological Chemistry|January 11, 2017
The Receptor-interacting Serine/Threonine Protein Kinase 1 (RIPK1) Regulates Progranulin LevelsAmanda R Mason, Lisa P Elia, Steven Finkbeiner
Neuropharmacology|January 22, 2020
Approaches to develop therapeutics to treat frontotemporal dementiaLisa P Elia, Terry Reisine, Amela Alijagic, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 10, 2014
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodiesGaia Skibinski, Ken Nakamura, Mark R Cookson, et al.
Cell and Tissue Research|December 14, 2017
iPS cells in the study of PD molecular pathogenesisMelanie M Cobb, Abinaya Ravisankar, Gaia Skibinski, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 31, 2019
Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome PathwayLisa P Elia, Amanda R Mason, Amela Alijagic, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Neurology|October 15, 2014
Targeting the low-hanging fruit of neurodegenerationAmanda R Mason, Adam Ziemann, Steven Finkbeiner
The Journal of Biological Chemistry|June 2, 2024
Three dimensional and four dimensional live imaging to study mechanisms of progressive neurodegenerationJeremy W Linsley, Terry Reisine, Steven Finkbeiner
Methods in Molecular Biology (Clifton, N.J.)|May 31, 2013
Longitudinal imaging and analysis of neurons expressing polyglutamine-expanded proteinsAndrey S Tsvetkov, D Michael Ando, Steven Finkbeiner
Stem Cell Research|November 4, 2021
Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson's patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)Gabriela Novak, Steven Finkbeiner, Gaia Skibinski, et al.
Stem Cell Research|November 26, 2021
Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson's disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)Gabriela Novak, Steven Finkbeiner, Gaia Skibinski, et al.
The Journal of Biological Chemistry|January 11, 2017
The Receptor-interacting Serine/Threonine Protein Kinase 1 (RIPK1) Regulates Progranulin LevelsAmanda R Mason, Lisa P Elia, Steven Finkbeiner
Neuropharmacology|January 22, 2020
Approaches to develop therapeutics to treat frontotemporal dementiaLisa P Elia, Terry Reisine, Amela Alijagic, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 10, 2014
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodiesGaia Skibinski, Ken Nakamura, Mark R Cookson, et al.
Cell and Tissue Research|December 14, 2017
iPS cells in the study of PD molecular pathogenesisMelanie M Cobb, Abinaya Ravisankar, Gaia Skibinski, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 31, 2019
Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome PathwayLisa P Elia, Amanda R Mason, Amela Alijagic, et al.
Pageof 15